GH Research Plc (GHRS)
21.01
-1.43
(-6.37%)
USD |
NASDAQ |
May 07, 16:00
21.01
0.00 (0.00%)
After-Hours: 20:00
GH Research Research and Development Expense (Annual) : 38.73M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Definium Therapeutics, Inc. | 117.66M |
| Compass Pathways Plc | 118.71M |
| Atai Beckley, Inc. | 53.06M |
| Jazz Pharmaceuticals Plc | 782.74M |
| Nektar Therapeutics | 117.07M |